Corporate-Overview
[wpseo_breadcrumb]

Axigen at a Glance

Axigen Healthcare, headquartered at Mumbai (India) is a global pharmaceutical company, was incorporated in May 2018 with an ambition to become a leading provider of healthcare products and services in India and beyond.
The essence of our culture is built on meeting global standards in every aspect of our business. Our key focus areas lie in the prescription drugs that have wide-ranging applications across fields like Gynaecology, Infertility Management, Science-based Nutritional Health, Cardio-Diabetic, Dermatology, Gastroenterology, Pain Management and Acute care. 

Our in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Our employees work to produce high-quality, high-volume formulations using cost efficient processes. And, our trained personnel are dedicated to ensuring compliance with international quality standards.

We have established world-class manufacturing partners by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances Our plants are WHO, cGMP, GLP, ISO 9001, ISO 22000, HACCP, PPB Kenya, NDA Uganda certified company. 

Our in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Our employees work to produce high-quality, high-volume formulations using cost efficient processes. And, our trained personnel are dedicated to ensuring compliance with international quality standards.

We are planning gradually building a meaningful presence in the Russia & CIS and US market, with selected product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years. It also has its marketing plan in emerging markets of African Countries: Zimbabwe, Kenya, Uganda, Nigeria and French West Africa; Asian Countries: Sri Lanka, Vietnam, Myanmar, Philippines, Malaysia, Nepal and Bangladesh; MENA (Middle East North Africa).

Our in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Our employees work to produce high-quality, high-volume formulations using cost efficient processes. And, our trained personnel are dedicated to ensuring compliance with international quality standards.

Our in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Our employees work to produce high-quality, high-volume formulations using cost efficient processes. And, our trained personnel are dedicated to ensuring compliance with international quality standards.

Axigen works with partners to in-license products in India and out-license products into other regions by capitalising on these collaborative strengths to capture and penetrate new markets.

According to Axigen’s Director, strategic partnerships are a less capital-intensive way of moving into new territories or acquiring new capabilities. By finding partners with complementary skills, Axigen endeavours to find smarter ways to grow and in turn create significant value for all its stakeholders.

We are planning gradually building a meaningful presence in the Russia & CIS and US market, with selected product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years. It also has its marketing plan in emerging markets of African Countries: Zimbabwe, Kenya, Uganda, Nigeria and French West Africa; Asian Countries: Sri Lanka, Vietnam, Myanmar, Philippines, Malaysia, Nepal and Bangladesh; MENA (Middle East North Africa).
Our core commitment is towards improving health care outcomes and adding value for all our stakeholders including patients, regulators, employees, business partners, an efficient field force, and our access to doctors across various specialties in India through four different marketing divisions Gynae Care , Nutri Care, Cardio-Diabetic Care, Derma Care and Acute Care We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally.
The Axigen Group was founded in May 2018 and is a leading business conglomerate in the country with businesses spanning the Shipping, Textile, Telecommunication, Building & Metal, Travel Sector and Pharmaceuticals. This comes on the back of a bold vision, a committed and energetic team, strong execution capabilities and a commitment to innovation, which the group has consistently demonstrated over time and across the businesses it participates in. The group is also firmly committed to giving back to the community through the charitable work. We now bring this demonstrated strength and commitment to revolutionize the Indian healthcare sector as well through our Axigen Healthcare business.

The company has achieved domestic recognition within a very short span of time and has major global expansion plans for the near future.